Autres langues Takara Bio Inc.

Actions

4974

JP3460200003

Marché Fermé - Japan Exchange Autres places de cotation 08:00:00 02/05/2024			Varia. 5j.	Varia. 1 janv.
1 010 ^JPY	-0,49 %		-0,49 %	-19,33 %

15/02	Le revenu attribuable de Takara Bio chute de 98,9 % au cours des neuf premiers mois de l'année fiscale	MT
2023	Takara Bio Inc. révise ses prévisions de résultats consolidés pour l'exercice se terminant le 31 mars 2024	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Takara Bio transforms single-cell landscape with new large-scale NGS profiling system for oncology biomarker discovery	03/04
Takara Bio Inc.(TSE:4974) dropped from FTSE All-World Index	18/03
Acute Lymphocytic Leukemia Pipeline, FDA Approvals, Clinical Trials Developments, and Companies 2024	22/02
Takara Bio's Attributable Income Falls 98.9% in Fiscal Nine Months	15/02
Takara Bio's first-to-market large-scale single-cell NGS profiling technologies poised to revolutionize biomarker discovery	06/02
Acute Lymphocytic Leukemia Pipeline, FDA Approvals, Clinical Trials Developments, and Companies 2023 (Updated)	22/12
Takara Bio USA wins EU opposition hearing, revoking Jumpcode Genomics NGS library enrichment patent	12/12
Takara Bio Inc. Revises Consolidated Earnings Guidance for the Year Ending March 31, 2024	09/11
Takara Bio : Annual Report 2023	13/09/23
Takara Bio : Financial Results Presentation (May 16, 2023)	29/05/23
Takara Bio : Notice of the 21th Annual General Meeting of Shareholders	23/05/23
Takara Bio : Consolidated Financial Statements for FY Ended March 31 2023	11/05/23
Takara Bio Inc. Reports Earnings Results for the Full Year Ended March 31, 2023	11/05/23
Takara Bio Inc. Provides Dividend Guidance for the Fiscal Year Ending Mar. 31, 2023	09/02/23
Takara Bio Inc. Revised Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2023	09/02/23
Takara Bio : Financial Results Presentation (November 15, 2022)	25/11/22
Takara Bio : Consolidated Financial Statements for the Second Quarter Ended September 30, 2022	10/11/22
Takara Bio Inc. Provides Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2023	10/11/22
Takara Bio Inc. Provides Dividend Guidance for the Fiscal Year Ending Mar. 31, 2023	10/11/22
Takara Bio : Consolidated Financial Statements for the First Quarter Ended June 30, 2023	04/08/22

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Takara Bio Inc.

Actions

4974

JP3460200003

Autres langues

Filtres